BioRegion Real Estate


GlaxoSmithKline Opens Singapore Biologics Vaccine Plant, Creates Endowment Fund

GlaxoSmithKline this week opened a S$600 million ($414 million) vaccine plant in Singapore's Tuas Business Park, in the Asian country's western section. The plant will begin production of GSK's pneumococcal conjugate vaccine, designed to combat meningitis, pneumonia, and blood poisoning, in 2011 following audits from the US Food and Drug Administration and the World Health Organization.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.